Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

JNK inhibitors for cardiovascular disorders claimed by Takeda

Aug. 3, 2004

Lexicon Genetics and Takeda team up on hypertension

July 30, 2004

Clinical study cleared to begin of HGF plasmid for ischemic heart disease

July 29, 2004

New phase II study of Titan's DITPA for CHF

July 29, 2004

Dual PDE3 inhibitors/beta-AR antagonists and their use in heart failure therapy

July 28, 2004

Pivotal trial cleared for Liberte paclitaxel-eluting coronary stent

July 27, 2004

Actelion claims new sulfamide-based endothelin antagonists

July 27, 2004

Antiarrhythmic compound from an Indian snake venom

July 23, 2004

Significant survival benefit in A-HeFT study of BiDil brings early conclusion

July 23, 2004

Mixed lineage kinase modulators described in a patent

July 22, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....